Trial · NCT07575009
Continuous Antibiotic Infusion In Children
NCT07575009, Phase 3, Recruiting, Tampere University Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Continuous Antibiotic Infusion In Children. Trials, record NCT07575009. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07575009
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Continuous Antibiotic Infusion In Children
- NCT number
- NCT07575009
- Status
- Recruiting
- Phases
- Phase 3
- Enrollment
- 150 participants, estimated
- Lead sponsor
- Tampere University Hospital
- Conditions
- Infection
- Interventions
- Benzylpenicillin
- First posted
- 2026-05-08
- Last updated
- 2026-05-08
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Cost of treatment | From hospitalization to the end of the continuous antibiotic infusion | Total treatment cost |
| Primary | Duration of fever | From the beginning of the disease to the end of the continuous antibiotic infusion | Number of days from antibiotic initiation to resolution of fever |
| Primary | Change in C-reactive protein (CRP) mg/ml | From hospitalization to the end of the continuous antibiotic infusion | Number of days from antibiotic initiation to normalization of values. Blood test are taken from all patiens D1 and D3 |
| Primary | Concomitant medications | From hospitalization to the end of the continuous antibiotic infusion | Time from antibiotic initiation to discontinuation of pain/fever medications or other supportive drugs |
| Primary | Parental absence from work (in days) | From hospitalization to the end of the continuous antibiotic infusion | |
| Primary | Distance from home to hospital (in kilometers) | In the beginning of the study | Geographic coverage of care |
| Primary | Duration of antibiotic treatment (in days) | From hospitalization to the end of the continuous antibiotic infusion, up to one month | Total duration including inpatient treatment and duration of continuous outpatient antibiotic therapy |
| Primary | Safety, measured with adverse events | Assessed from study initiation up to three months thereafter | |
| Primary | Emergency or clinic visits | Assessed from discontinuation of continuous antibiotic infusion up to one month thereafter | |
| Secondary | : The incidence of IV route problems | From the beginning of continuous antibiotic infusion to the end of the continuous antibiotic infusion, up to one month |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07575009
GET https://conductscience.org/api/trials/v1/NCT07575009/registered